dronabinol has been researched along with cp-55,940 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Blond, O; Briley, EM; Felder, CC; Joyce, KE; Lai, Y; Ma, AL; Mackie, K; Mansouri, J; Mitchell, RL | 1 |
| Abood, ME; Compton, DR; Martin, BR; Showalter, VM | 1 |
| Bianchi, A; Cruciani, G; Fichera, M; Musumarra, G | 1 |
| Fowler, CJ; Lambert, DM | 1 |
| Gynther, J; Järvinen, T; Lahtela-Kakkonen, M; Laitinen, JT; Nevalainen, T; Parkkari, T; Poso, A; Salo, OM; Savinainen, JR | 1 |
| Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
| Huffman, JW; Martin, BR; Thompson, AL; Wiley, JL | 1 |
| Bratton, SM; Brents, LK; Chimalakonda, KC; Endres, GW; Hollenberg, PF; James, LP; Moran, CL; Moran, JH; Prather, PL; Radominska-Pandya, A; Seely, KA | 1 |
| Bräse, S; Gläser, F; Müller, CE; Nieger, M; Rempel, V; Volz, N | 1 |
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Chicca, A; Curini, M; Gertsch, J; Messina, F; Pelosi, A; Petrucci, V; Rosati, O | 1 |
| Chung, S; Dangott, LJ; Huang, H; Kier, AB; Landrock, D; Landrock, KK; Li, S; Martin, GG; McIntosh, AL; Schroeder, F | 1 |
| Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
| Belardo, C; Cannazza, G; Citti, C; Forni, F; Gigli, G; Laganà, A; Linciano, P; Luongo, L; Maione, S; Montone, CM; Vandelli, MA | 1 |
| Ho, TC; Makriyannis, A; Nikas, SP; Tius, MA; Tong, F; Tran, NK; Zhou, H; Zvonok, N | 1 |
| Bohn, LM; Brust, CA; Georgiadis, MO; Iliopoulos-Tsoutsouvas, C; Ji, L; Ma, X; Makriyannis, A; Nikas, SP; Papanastasiou, IP; Paronis, CA; Tong, F; Tran, NK; Wood, JT; Zvonok, N | 1 |
3 review(s) available for dronabinol and cp-55,940
| Article | Year |
|---|---|
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid | 2005 |
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
13 other study(ies) available for dronabinol and cp-55,940
| Article | Year |
|---|---|
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Amidohydrolases; Animals; Arachidonic Acids; Base Sequence; Binding, Competitive; Calcium; Calcium Channel Blockers; Cannabinoids; CHO Cells; Cricetinae; Endocannabinoids; Enzyme Activation; Humans; Intracellular Fluid; Ion Channels; Kinetics; Mice; Molecular Sequence Data; Phospholipases; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Transfection | 1995 |
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Topics: Animals; Binding, Competitive; Brain; Cannabinoids; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Cyclohexanols; Guanine Nucleotides; Humans; Ligands; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; Sodium; Structure-Activity Relationship; Transfection | 1996 |
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
Topics: Arachidonic Acids; Cannabinoids; Drug Design; Endocannabinoids; Indoles; Ligands; Models, Biological; Models, Molecular; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 2000 |
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
Topics: Animals; Cannabinoid Receptor Modulators; Cerebellum; GTP-Binding Proteins; In Vitro Techniques; Ligands; Male; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2006 |
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.
Topics: Cannabinoids; Cyclohexanols; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2008 |
Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Brain; Cannabinoids; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Dronabinol; Humans; Hydroxylation; Illicit Drugs; Indoles; Kinetics; Ligands; Liver; Mass Spectrometry; Mice; Microsomes, Liver; Naphthalenes; Oxidation-Reduction; Protein Binding; Pyrans; Receptor, Cannabinoid, CB1 | 2012 |
Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.
Topics: Allosteric Site; Animals; CHO Cells; Coumarins; Cricetinae; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2013 |
One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Topics: Chemistry Techniques, Synthetic; Dronabinol; Humans; Microwaves; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substrate Specificity; Xanthenes | 2014 |
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.
Topics: Animals; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Fluorescent Dyes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cannabinoid | 2016 |
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Mice; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Oxa-adamantyl cannabinoids.
Topics: Cannabinoids; Dose-Response Relationship, Drug; Humans; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2021 |
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists.
Topics: Dronabinol; Receptor, Cannabinoid, CB1; Structure-Activity Relationship | 2022 |